These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 17703512)
1. Options sought after drug study. Patients who take rosiglitazone might consider pioglitazone instead. Heart Advis; 2007 Jul; 10(7):9. PubMed ID: 17703512 [No Abstract] [Full Text] [Related]
2. Rosiglitazone and pioglitazone in the treatment of diabetes mellitus. Odom J; Williamson B; Carter L Am J Health Syst Pharm; 2008 Oct; 65(19):1846-50. PubMed ID: 18796427 [No Abstract] [Full Text] [Related]
3. The value equation for rosiglitazone and pioglitazone in older persons. Zarowitz BJ Geriatr Nurs; 2008; 29(1):9-11. PubMed ID: 18267172 [No Abstract] [Full Text] [Related]
4. Pioglitazone is a valid alternative to rosiglitazone. Derosa G Am J Cardiovasc Drugs; 2011 Dec; 11(6):357-62. PubMed ID: 21950735 [TBL] [Abstract][Full Text] [Related]
5. The "glitazones": rosiglitazone and pioglitazone. Papoushek C J Obstet Gynaecol Can; 2003 Oct; 25(10):853-7. PubMed ID: 14532954 [TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events. Starner CI; Schafer JA; Heaton AH; Gleason PP J Manag Care Pharm; 2008; 14(6):523-31. PubMed ID: 18693776 [TBL] [Abstract][Full Text] [Related]
7. [The benefit of pioglitazone in patients with diabetes mellitus type 2 and cardiovascular complications]. Olsovský J Vnitr Lek; 2005 Dec; 51(12):1412. PubMed ID: 16430111 [No Abstract] [Full Text] [Related]
8. Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by Floyd et al. Osei SY; Koro CE; Cobitz AR; Kolatkar NS; Stender M Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1244-6. PubMed ID: 19655316 [No Abstract] [Full Text] [Related]
9. Commentary on 'Case series of liver failure associated with rosiglitazone and pioglitazone' by James Floyd et al. Beiderbeck AB; Sakaguchi M Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1247-9. PubMed ID: 19842093 [No Abstract] [Full Text] [Related]
11. [Uncertainly after publications on glitazones. Elevated myocardial infarction risk is not a class effect]. Erdmann E; Scherbaum WA MMW Fortschr Med; 2007 Dec; 149(49-50):49-50. PubMed ID: 18236983 [No Abstract] [Full Text] [Related]
12. [Treatment of patients with type 2 diabetes mellitus with pioglitazone. A survey of a Cochrane review]. Madsbad S Ugeskr Laeger; 2007 Nov; 169(47):4054-7. PubMed ID: 18078659 [No Abstract] [Full Text] [Related]